Functional assessment of distal regulatory SNPs associated with type 1 diabetes.

与 1 型糖尿病相关的远端调节 SNP 的功能评估。

基本信息

  • 批准号:
    9934717
  • 负责人:
  • 金额:
    $ 29.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Type 1 diabetes (T1D) is an autoimmune disease resulting in the loss of insulin- producing cells. Genetic studies, including those in twins, sugget a strong genetic basis for this disease. Genome-wide association studies (GWASs) have produced large numbers of T1D-associated single-nucleotide polymorphisms (SNPs), but often fail to determine a causative mutation. This may be due to the complexity of the disease; or in part, due to many associated SNPs lying outside of gene coding regions. A recent assessment of GWASs illustrated that 45% of disease or trait associated SNPs fell in introns, while 43% lie in intergenic regions. Global methods for determining chromatin states have shown that associated SNPs can overlap distal regulatory regions such as enhancers. We have constructed enhancer maps based H3K4me1 localization in isolated, human T cells. We analyzed the T1D-associated SNPs from the NHGRI GWAS catalog for overlap with our global T helper cell enhancer predictions. Using 1000 Genomes data we identified additional SNPs in linkage disequilibrium to expand the number of T1D-associated SNPs at enhancer elements. Goal: Our goal is to functionally validate T1D-associated rSNPs. We will use a series of high- throughput assays and systematic evaluation to determine the most functionally relevant rSNPs. We will also determine the target genes of enhancers overlapping T1D SNPs in order to identify new genes important in the etiology of T1D pathogenesis. We will do so through the following specific aims. Specific Aim 1. Determine the effect of T1D rSNPs on enhancer activity. Specific Aim 2. Determine if TF binding is disrupted at T1D-associated enhancer SNPs. Specific Aim 3. Identification of target genes for enhancers harboring associated SNPs.
 描述(由申请人提供):1 型糖尿病 (T1D) 是一种导致胰岛素生成细胞丧失的自身免疫性疾病。遗传学研究,包括双胞胎的研究,表明这种疾病有很强的遗传基础。全基因组关联研究 (GWAS) 已产生大量与 T1D 相关的单核苷酸多态性 (SNP),但往往无法确定致病突变。这可能是由于疾病的复杂性;或者部分是由于许多相关的 SNP 位于基因编码区之外。最近的 GWAS 评估表明,45% 的疾病或性状相关 SNP 落在内含子中,而 43% 位于基因间区域。用于确定染色质状态的全局方法表明,相关的 SNP 可以与增强子等远端调控区域重叠。我们在分离的人类 T 细胞中构建了基于 H3K4me1 定位的增强子图谱。我们分析了 NHGRI GWAS 目录中与 T1D 相关的 SNP,以了解与我们的全球 T 辅助细胞增强子预测的重叠情况。使用 1000 个基因组数据,我们确定了连锁不平衡中的其他 SNP,以扩大增强子元件处 T1D 相关 SNP 的数量。目标:我们的目标是对 T1D 相关 rSNP 进行功能验证。我们将使用一系列高通量测定和系统评估来确定功能最相关的 rSNP。我们还将确定与 T1D SNP 重叠的增强子的靶基因,以便识别在 T1D 发病机制中重要的新基因。我们将通过以下具体目标来实现这一目标。具体目标 1. 确定 T1D rSNP 对增强子活性的影响。具体目标 2. 确定 T1D 相关增强子 SNP 处的 TF 结合是否被破坏。具体目标 3. 鉴定含有相关 SNP 的增强子的靶基因。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Epigenomic Landscapes of hESC-Derived Neural Rosettes: Modeling Neural Tube Formation and Diseases.
  • DOI:
    10.1016/j.celrep.2017.07.036
  • 发表时间:
    2017-08-08
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Valensisi C;Andrus C;Buckberry S;Doni Jayavelu N;Lund RJ;Lister R;Hawkins RD
  • 通讯作者:
    Hawkins RD
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raymond David Hawkins其他文献

Raymond David Hawkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raymond David Hawkins', 18)}}的其他基金

Three-dimensional conformation changes associated with T cell memory and autoimmunity
与 T 细胞记忆和自身免疫相关的三维构象变化
  • 批准号:
    10115995
  • 财政年份:
    2020
  • 资助金额:
    $ 29.49万
  • 项目类别:
Three-dimensional conformation changes associated with T cell memory and autoimmunity
与 T 细胞记忆和自身免疫相关的三维构象变化
  • 批准号:
    10456277
  • 财政年份:
    2020
  • 资助金额:
    $ 29.49万
  • 项目类别:
Three-dimensional conformation changes associated with T cell memory and autoimmunity
与 T 细胞记忆和自身免疫相关的三维构象变化
  • 批准号:
    10689314
  • 财政年份:
    2020
  • 资助金额:
    $ 29.49万
  • 项目类别:
Three-dimensional conformation changes associated with T cell memory and autoimmunity
与 T 细胞记忆和自身免疫相关的三维构象变化
  • 批准号:
    10264086
  • 财政年份:
    2020
  • 资助金额:
    $ 29.49万
  • 项目类别:
Functional assessment of distal regulatory SNPs associated with type 1 diabetes.
与 1 型糖尿病相关的远端调节 SNP 的功能评估。
  • 批准号:
    9769721
  • 财政年份:
    2015
  • 资助金额:
    $ 29.49万
  • 项目类别:
Functional assessment of distal regulatory SNPs associated with type 1 diabetes.
与 1 型糖尿病相关的远端调节 SNP 的功能评估。
  • 批准号:
    9118987
  • 财政年份:
    2015
  • 资助金额:
    $ 29.49万
  • 项目类别:
Functional validation of Rheumatoid Arthritis-associated distal regulatory SNPs i
类风湿关节炎相关远端调节 SNP 的功能验证 i
  • 批准号:
    8810054
  • 财政年份:
    2015
  • 资助金额:
    $ 29.49万
  • 项目类别:
Effects of PAHs on the Epigenome and Differentiation Capacity of Embryonic and Ne
PAHs对胚胎和神经细胞表观基因组和分化能力的影响
  • 批准号:
    8536291
  • 财政年份:
    2012
  • 资助金额:
    $ 29.49万
  • 项目类别:
Small-scale chromatin preparation and ChIP-seq aided by in vitro transposition
体外转座辅助的小规模染色质制备和 ChIP-seq
  • 批准号:
    8463011
  • 财政年份:
    2012
  • 资助金额:
    $ 29.49万
  • 项目类别:
Small-scale chromatin preparation and ChIP-seq aided by in vitro transposition
体外转座辅助的小规模染色质制备和 ChIP-seq
  • 批准号:
    8309590
  • 财政年份:
    2012
  • 资助金额:
    $ 29.49万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Studentship
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Operating Grants
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
    Salary Programs
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
  • 批准号:
    10637048
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
  • 批准号:
    10678307
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
  • 批准号:
    10664599
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 29.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了